Böhlen P, Baird A, Esch F, Ling N, Gospodarowicz D
Proc Natl Acad Sci U S A. 1984 Sep;81(17):5364-8. doi: 10.1073/pnas.81.17.5364.
Fibroblast growth factor (FGF) has been purified to homogeneity from bovine pituitaries by two methods. Starting material for both methods was an FGF preparation partially purified as described by Gospodarowicz [Gospodarowicz, D. (1975) J. Biol. Chem. 250, 2515-2520]. Purification procedure I involved cation-exchange and reversed-phase HPLC, while procedure II employed gel filtration and ion-exchange chromatography. Isolation was monitored by testing column fractions for their capacity to stimulate the proliferation of vascular endothelial cells in vitro. The growth factor has an approximate molecular weight of 16,000. Its amino-terminal sequence was determined as Pro-Ala-Leu-Pro-Glu-Asp-Gly-Gly-Ser-Gly-Ala-Phe-Pro-Pro-Gly. Sequence and amino acid composition indicate that the structure of pituitary FGF is different from that of other known growth factors. Pituitary FGF, as isolated under nonacidic conditions (procedure II), has high potency and intrinsic activity to stimulate adult bovine aortic endothelial cells (half-maximal proliferation at 2 pM). Acidic conditions as in procedure I, however, lead to about 90% loss of potency while the intrinsic activity remains intact (identical maximal stimulation values). By all other criteria (molecular weight, amino acid composition, amino-terminal sequence), the two preparations are indistinguishable. Antibodies were raised in rabbits against a synthetic peptide representing the first nine residues of the amino-terminal sequence of the pituitary FGF. The polyclonal antibodies recognize the synthetic peptide and the purified growth factor on an equimolar basis and are capable of inhibiting mitogenic activity in vitro. This report describes a partial chemical characterization of a pituitary FGF and demonstrates rigorously that the characterized protein possesses the mitogenic activity commonly referred to as "basic pituitary FGF."
已通过两种方法从牛垂体中纯化出均一的成纤维细胞生长因子(FGF)。两种方法的起始材料都是如戈斯波达罗维茨所述[戈斯波达罗维茨,D.(1975年)《生物化学杂志》250,2515 - 2520]部分纯化的FGF制剂。纯化程序I涉及阳离子交换和反相高效液相色谱,而程序II采用凝胶过滤和离子交换色谱。通过检测柱级分在体外刺激血管内皮细胞增殖的能力来监测分离过程。该生长因子的分子量约为16,000。其氨基末端序列确定为Pro - Ala - Leu - Pro - Glu - Asp - Gly - Gly - Ser - Gly - Ala - Phe - Pro - Pro - Gly。序列和氨基酸组成表明垂体FGF的结构与其他已知生长因子不同。在非酸性条件下(程序II)分离的垂体FGF对刺激成年牛主动脉内皮细胞具有高效能和内在活性(在2 pM时达到半数最大增殖)。然而,如程序I中的酸性条件会导致效能损失约90%,而内在活性保持完整(相同的最大刺激值)。根据所有其他标准(分子量、氨基酸组成、氨基末端序列),这两种制剂无法区分。用针对代表垂体FGF氨基末端序列前九个残基的合成肽在兔中制备抗体。多克隆抗体以等摩尔基础识别合成肽和纯化的生长因子,并且能够在体外抑制促有丝分裂活性。本报告描述了垂体FGF的部分化学特性,并严格证明所表征的蛋白质具有通常称为“碱性垂体FGF”的促有丝分裂活性。